UMIN ID: UMIN000002377
Registered date:28/04/2010
PEG-IFN-alfa2b/Ribavirin combination therapy for chronic hepatitis C patients with low platelet count: efficacy and safety
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | chronic hepatitis C |
| Date of first enrollment | 2009/10/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Peg-IFN-alfa2b/Ribavirin thrapy |
Outcome(s)
| Primary Outcome | Efficacy |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | contraindication of Peg-IFN/Ribavirin thrapy |
Related Information
| Primary Sponsor | Kanazawa university |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Kanazawa university |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| s-kaneko@umin.ac.jp | |
| Affiliation | Kanazawa university University hospital |
| scientific contact | |
| Name | Shuichi Kaneko |
| Address | Takara-Machi, Kanazawa, Ishikawa, Japan Japan |
| Telephone | |
| Affiliation | Kanazawa university Graduate school of meicine |